# FDA recall D-1076-2019

> **Pacific Compounding Pharmacy & Consultations Inc** · Class II · drug recall initiated 2018-08-23.

## Product

Cefuroxime 10mg/mL INJ 0.5 mg, SDV, Rx only, Pacific Compounding, Stockton, CA

## Reason for recall

Presence of Particulate Matter: Particulate matter was reported in one lot of Cefuroxime by a physician after use of product.. FDA analysis identified the particulate as coring of the rubber stopper

## Distribution

California

## Key facts

- **Recall number:** D-1076-2019
- **Recalling firm:** Pacific Compounding Pharmacy & Consultations Inc
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2018-08-23
- **Report date:** 2019-04-10
- **Termination date:** 2023-04-27

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Stockton, CA, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1076-2019

## Citation

> AI Analytics. FDA recall D-1076-2019. Retrieved 2026-06-25 from https://api.ai-analytics.org/recall/D-1076-2019. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*